← Back to Search

Psychological Assessment

FACS for Chronic Pain (FACS-Fr Trial)

N/A
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7
Awards & highlights

FACS-Fr Trial Summary

This trial is testing a new scale to measure fear avoidance in people with chronic musculoskeletal disorders.

Eligible Conditions
  • Chronic Pain
  • Fear of Movement

FACS-Fr Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
FACS
HADS
PCS
+1 more

FACS-Fr Trial Design

1Treatment groups
Experimental Treatment
Group I: Chronic painExperimental Treatment1 Intervention
Fear-avoidance components scale
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FACS
2022
N/A
~50

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
292 Previous Clinical Trials
69,391 Total Patients Enrolled
11 Trials studying Chronic Pain
1,098 Patients Enrolled for Chronic Pain
Guillaume Leonard, PrStudy DirectorUniversité de Sherbrooke
1 Previous Clinical Trials
24 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for enrolment in this trial?

"Clinicaltrials.gov currently lists this trial as actively recruiting patients, with the initial posting occurring on February 1st 2022 and recent edits made on May 18th 2022."

Answered by AI

To what extent has the population been recruited for this experiment?

"Affirmative. Data hosted on clinicaltrials.gov confirms that this medical trial, first posted on February 1st 2022, is actively seeking recruits. Fifty subjects must be recruited from a single location for the study to proceed as planned."

Answered by AI
~16 spots leftby Apr 2025